Novo Nordisk Partners with Amazon to Boost Drug Discovery

Novo Nordisk has partnered with Amazon Web Services to accelerate drug discovery using AI and cloud technologies, establishing a co-innovation hub in London to reduce the time from drug target identification to first human dose.

This Wire brief sits within Fusion42's coverage of Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.